Literature DB >> 18992367

The behavioral consequences of exposure to antiepileptic drugs in utero.

J Vinten1, R L Bromley, J Taylor, N Adab, U Kini, G A Baker.   

Abstract

The aim of the study was to examine the behavior of 242 children, aged between 6 and 16 years, born to mothers with epilepsy. Exposure to sodium valproate (VPA) in utero was associated with high levels of parental stress induced by the child's maladaptive behavior. These children were also poorer for daily living skills and skills relating to socialization. The outcomes on both measures were strongly affected by the Full Scale IQ (FSIQ) of the child; however, no significant differences were found between the groups and therefore this pattern of results cannot simply be attributed to a lower FSIQ. The results of this study suggest that exposure to VPA in utero and the presence of a lowered FSIQ are risk factors for the development of poorer adaptive behavior and a higher rate of maladaptive behaviors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992367     DOI: 10.1016/j.yebeh.2008.10.011

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  21 in total

Review 1.  Developmental effects of antiepileptic drugs and the need for improved regulations.

Authors:  Kimford J Meador; David W Loring
Journal:  Neurology       Date:  2015-10-30       Impact factor: 9.910

2.  Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years.

Authors:  Morris J Cohen; Kimford J Meador; Nancy Browning; Ryan May; Gus A Baker; Jill Clayton-Smith; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  Epilepsy Behav       Date:  2013-09-05       Impact factor: 2.937

3.  Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy.

Authors:  Gyri Veiby; Anne Kjersti Daltveit; Bernt A Engelsen; Nils Erik Gilhus
Journal:  J Neurol       Date:  2014-01-22       Impact factor: 4.849

4.  Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age.

Authors:  Kimford J Meador; Gus A Baker; Nancy Browning; Morris J Cohen; Jill Clayton-Smith; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  Brain       Date:  2011-01-11       Impact factor: 13.501

Review 5.  Antiepileptic drugs and pregnancy outcomes.

Authors:  Bogdan J Wlodarczyk; Ana M Palacios; Timothy M George; Richard H Finnell
Journal:  Am J Med Genet A       Date:  2012-06-18       Impact factor: 2.802

6.  Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation program study.

Authors:  William V Bobo; Robert L Davis; Sengwee Toh; De-Kun Li; Susan E Andrade; T Craig Cheetham; Pamala Pawloski; Sascha Dublin; Simone Pinheiro; Tarek Hammad; Pamela E Scott; Richard A Epstein; Patrick G Arbogast; James A Morrow; Judith A Dudley; Jean M Lawrence; Lyndsay A Avalos; William O Cooper
Journal:  Paediatr Perinat Epidemiol       Date:  2012-11       Impact factor: 3.980

Review 7.  Antiepileptic drugs in women with epilepsy during pregnancy.

Authors:  Evan Gedzelman; Kimford J Meador
Journal:  Ther Adv Drug Saf       Date:  2012-04

8.  Exposure to antiepileptic drugs in utero and child development: a prospective population-based study.

Authors:  Gyri Veiby; Anne K Daltveit; Synnve Schjølberg; Camilla Stoltenberg; Anne-Siri Øyen; Stein E Vollset; Bernt A Engelsen; Nils E Gilhus
Journal:  Epilepsia       Date:  2013-07-19       Impact factor: 5.864

Review 9.  An Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment Outcomes.

Authors:  Elizabeth E Gerard; Kimford J Meador
Journal:  J Pediatr Genet       Date:  2015-06

10.  Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine.

Authors:  Uma Deshmukh; Jane Adams; Eric A Macklin; Ruby Dhillon; Katherine D McCarthy; Barbara Dworetzky; Autumn Klein; Lewis B Holmes
Journal:  Neurotoxicol Teratol       Date:  2016-01-12       Impact factor: 3.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.